Companies House 13684615 2025-10-31 2025-10-31 2024-11-01 false iso4217:GBP xbrli:pure 13684615 2023-11-01 2024-10-31 13684615 2025-10-31 13684615 2024-11-01 2025-10-31 13684615 2024-10-31 13684615 curr:PoundSterling 2024-11-01 2025-10-31 13684615 uk-bus:CompanyLimitedByGuarantee 2024-11-01 2025-10-31 13684615 uk-bus:FRS102 2024-11-01 2025-10-31 13684615 uk-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 13684615 uk-bus:FullAccounts 2024-11-01 2025-10-31 13684615 uk-bus:RegisteredOffice 2024-11-01 2025-10-31 13684615 uk-bus:Director1 2024-11-01 2025-10-31 13684615 uk-bus:Director2 2024-11-01 2025-10-31 13684615 uk-bus:Director3 2024-11-01 2025-10-31 13684615 uk-bus:Director4 2024-11-01 2025-10-31 13684615 uk-bus:Director5 2024-11-01 2025-10-31 13684615 uk-bus:Director6 2024-11-01 2025-10-31 13684615 uk-bus:Director7 2024-11-01 2025-10-31 13684615 uk-bus:Director8 2024-11-01 2025-10-31 13684615 uk-bus:Director9 2024-11-01 2025-10-31 13684615 uk-bus:Director10 2024-11-01 2025-10-31 13684615 uk-bus:Director11 2024-11-01 2025-10-31 13684615 uk-bus:Director12 2024-11-01 2025-10-31 13684615 uk-bus:Director13 2024-11-01 2025-10-31 13684615 uk-bus:Director14 2024-11-01 2025-10-31 13684615 uk-bus:Director15 2024-11-01 2025-10-31 13684615 uk-bus:Director16 2024-11-01 2025-10-31 13684615 uk-bus:Director17 2024-11-01 2025-10-31 13684615 uk-bus:Director18 2024-11-01 2025-10-31 13684615 uk-bus:Director19 2024-11-01 2025-10-31 13684615 uk-bus:Director20 2024-11-01 2025-10-31 13684615 uk-bus:Director21 2024-11-01 2025-10-31 13684615 uk-bus:CompanySecretary1 2024-11-01 2025-10-31 13684615 core:AfterOneYear 2025-10-31 13684615 core:AfterOneYear 2024-10-31 13684615 core:WithinOneYear 2025-10-31 13684615 core:WithinOneYear 2024-10-31 13684615 core:WithinOneYear 2024-11-01 2025-10-31 13684615 core:AfterOneYear 2025-10-31 13684615 core:AfterOneYear 2024-10-31 13684615 core:AfterOneYear 2024-11-01 2025-10-31 13684615 core:ShareCapital 2025-10-31 13684615 core:ShareCapital 2024-10-31 13684615 core:SharePremium 2025-10-31 13684615 core:SharePremium 2024-10-31 13684615 core:OtherReservesSubtotal 2025-10-31 13684615 core:OtherReservesSubtotal 2024-10-31 13684615 core:RevaluationReserve 2025-10-31 13684615 core:RevaluationReserve 2024-10-31 13684615 core:RetainedEarningsAccumulatedLosses 2025-10-31 13684615 core:RetainedEarningsAccumulatedLosses 2024-10-31 13684615 1 2024-11-01 2025-10-31 13684615 2 2024-11-01 2025-10-31 13684615 3 2024-11-01 2025-10-31 13684615 core:LandBuildings 2024-11-01 2025-10-31 13684615 core:LandBuildings 2025-10-31 13684615 core:LandBuildings 2023-11-01 2024-10-31 13684615 core:LandBuildings 2024-10-31 13684615 core:PlantMachinery 2024-11-01 2025-10-31 13684615 core:PlantMachinery 2025-10-31 13684615 core:PlantMachinery 2023-11-01 2024-10-31 13684615 core:PlantMachinery 2024-10-31 13684615 core:FurnitureFittingsToolsEquipment 2024-11-01 2025-10-31 13684615 core:FurnitureFittingsToolsEquipment 2025-10-31 13684615 core:FurnitureFittingsToolsEquipment 2023-11-01 2024-10-31 13684615 core:FurnitureFittingsToolsEquipment 2024-10-31 13684615 core:OfficeEquipment 2024-11-01 2025-10-31 13684615 core:OfficeEquipment 2025-10-31 13684615 core:OfficeEquipment 2023-11-01 2024-10-31 13684615 core:OfficeEquipment 2024-10-31 13684615 core:Vehicles 2024-11-01 2025-10-31 13684615 core:Vehicles 2025-10-31 13684615 core:Vehicles 2023-11-01 2024-10-31 13684615 core:Vehicles 2024-10-31 13684615 core:NetGoodwill 2024-11-01 2025-10-31 13684615 core:NetGoodwill 2025-10-31 13684615 core:NetGoodwill 2023-11-01 2024-10-31 13684615 core:NetGoodwill 2024-10-31 13684615 core:IntangibleAssetsOtherThanGoodwill 2024-11-01 2025-10-31 13684615 core:IntangibleAssetsOtherThanGoodwill 2025-10-31 13684615 core:IntangibleAssetsOtherThanGoodwill 2023-11-01 2024-10-31 13684615 core:IntangibleAssetsOtherThanGoodwill 2024-10-31

# BRISTOL COMMUNITY ACUPUNCTURE CIC

## Company limited by guarantee

## Company Registration Number:
13684615 (England and Wales)

## Unaudited statutory accounts for the year ended 31 October 2025

## Period of accounts

## Start date: 1 November 2024

## End date: 31 October 2025

# BRISTOL COMMUNITY ACUPUNCTURE CIC

## Contents of the Financial Statements

for the Period Ended 31 October 2025

Balance sheet |
Additional notes |
Balance sheet notes |
Community Interest Report |

# BRISTOL COMMUNITY ACUPUNCTURE CIC

## Balance sheet

As at 31 October 2025

| Notes | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Fixed assets
Tangible assets: | 3 | 1,000 | 500
Total fixed assets: |  | 1,000 | 500
Current assets
Cash at bank and in hand: |  | 8,282 | 8,394
Total current assets: |  | 8,282 | 8,394
Net current assets (liabilities): |  | 8,282 | 8,394
Total assets less current liabilities: |  | 9,282 | 8,894
Total net assets (liabilities): |  | 9,282 | 8,894
Members' funds
Profit and loss account: |  | 9,282 | 8,894
Total members' funds: |  | 9,282 | 8,894

The notes form part of these financial statements

# BRISTOL COMMUNITY ACUPUNCTURE CIC

## Balance sheet statements

For the year ending 31 October 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 20 July 2026
and signed on behalf of the board by:

Name: Ian Fitzpatrick
Status: Director

The notes form part of these financial statements

# BRISTOL COMMUNITY ACUPUNCTURE CIC

## Notes to the Financial Statements

for the Period Ended 31 October 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

  Turnover policy

  Turnover represents the total income received from normal business activities during the financial year, excluding VAT. Revenue from acupuncture treatment services is recognised when the treatment is provided.

# BRISTOL COMMUNITY ACUPUNCTURE CIC

## Notes to the Financial Statements

for the Period Ended 31 October 2025

- ## 2. Employees

  | 2025 | 2024
  --- | --- | ---
  Average number of employees during the period | 2 | 2

# BRISTOL COMMUNITY ACUPUNCTURE CIC

## Notes to the Financial Statements

for the Period Ended 31 October 2025

## 3. Tangible assets

| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total
--- | --- | --- | --- | --- | --- | ---
Cost | £ | £ | £ | £ | £ | £
At 1 November 2024 |  |  |  | 500 |  | 500
Additions |  |  |  | 500 |  | 500
Disposals |  |  |  |  |  |
Revaluations |  |  |  |  |  |
Transfers |  |  |  |  |  |
At 31 October 2025 |  |  |  | 1,000 |  | 1,000
Depreciation |  |  |  |  |  |
At 1 November 2024 |  |  |  |  |  |
Charge for year |  |  |  |  |  |
On disposals |  |  |  |  |  |
Other adjustments |  |  |  |  |  |
At 31 October 2025 |  |  |  |  |  |
Net book value |  |  |  |  |  |
At 31 October 2025 |  |  |  | 1,000 |  | 1,000
At 31 October 2024 |  |  |  | 500 |  | 500

# COMMUNITY INTEREST ANNUAL REPORT

### BRISTOL COMMUNITY ACUPUNCTURE CIC

### Company Number: 13684615 (England and Wales)

### Year Ending: 31 October 2025

Company activities and impact

Bristol Community Acupuncture operates two clinics in Bristol offering low-cost acupuncture treatment to the local community. In the financial year to 31 October 2025, we provided approximately 1,500 treatments across our two sites at Cassell Road and St Annes House. We operate on a twice-weekly schedule, offering six-hour clinics with a capacity of around 30 treatments per week. Our service is designed to reach people with limited access to acupuncture due to cost or mobility barriers. The majority of our clients are people on low or no income, many managing chronic health conditions such as pain, anxiety, and musculoskeletal issues. We also provided a number of free treatments funded through Community Lottery grants, ensuring that cost is never a barrier to access.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

Two directors received remuneration during the financial year. Each received £150 per day for clinical and operational work. No additional benefits were received. Remuneration was set at a level appropriate to the part-time nature of the work and the social enterprise's modest turnover.

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
20 July 2026

And signed on behalf of the board by:
Name: Ian Fitzpatrick
Status: Director